Darien, CT · Founded 2006 · Privately Held (backing)
Operator of a bio-pharmaceutical company intended to assist with the discovery and development of safe and innovative treatments to finally resolve moderate to severe pain. Cytogel Pharma is based in Darien, CT and was founded in 2006. It was valued at $47 million at its later-stage round in Oct 2024, the last priced event on record. It has raised $32.8 million across 4 recorded rounds; the latest was a $1.8 million seed round in Jun 2023.
PMV mark · valuation
$47.0M
Oct 2026
Priced at
its later-stage round
Oct 2024
Total raised
$32.8M
Last round
Seed Round
Jun 2023
Cap table — not yet on record
Cytogel Pharma's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Cytogel Pharma with a free account
·Watch Cytogel Pharma: the Monday email on marks, rounds and moves
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Cytogel Pharma's 4 recorded funding rounds.
